Studies on EBV efficacy of 3 were investigated on tumor growth inhibition via the MAPK/ERK signaling pathway in nude mice and on reduction of cell viability via the p53-related signaling pathway targeting XAF1 and GADD45α expressions via the mitochondria-dependent pathway [55,56]. The gene discussed is XAF1; the disease is neoplasm.